Trial Profile
A Multicenter, Open-label, Single-arm Study to Evaluate the Long-term Use of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2017
Price :
$35
*
At a glance
- Drugs Clonidine (Primary)
- Indications Diabetic neuropathies
- Focus Adverse reactions
- Sponsors BioDelivery Sciences International
- 04 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Feb 2015 New trial record